# Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

> **NCT02680847** · PHASE4 · TERMINATED · sponsor: **Pfizer** · enrollment: 32 (actual)

## Conditions studied

- Moderate-severe Pain

## Interventions

- **DRUG:** ALO-02

## Key facts

- **NCT ID:** NCT02680847
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01-21
- **Primary completion:** 2018-01-10
- **Final completion:** 2018-01-24
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** The trial was terminated on 08FEB2018. Pfizer has decided to withdraw the New Drug Application and has notified FDA. There are no efficacy or safety concerns.
- **Last updated:** 2018-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02680847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02680847, "Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02680847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*